Table 2.
mRs ≤ 2 (N = 157) |
mRs > 2 (N = 73) |
P | P * | |
---|---|---|---|---|
Age | 65.1 ± 15.5 | 72.2 ± 15 | <0.001 | 0.398 |
Male | 90 (39.1%) | 36 (15.7%) | 0.256 | — |
Smoking | 25 (10.1%) | 9 (3.9%) | 0.463 | — |
Hypertension | 105 (45.7%) | 58 (25.2%) | 0.061 | — |
Obesity | 15 (6.5%) | 7 (3%) | 0.993 | — |
Family history | 12 (5.2%) | 4 (1.7%) | 0.548 | — |
Diabetes | 60 (26.1%) | 29 (12.6%) | 0.827 | — |
Previous stroke | 42 (18.3%) | 19 (8.3%) | 0.908 | — |
Weakness and numbness | 109 (47.4%) | 54 (23.5%) | 0.307 | — |
Confusion, speech difficulties, and comprehension problems | 53 (23%) | 38 (16.5%) | 0.017 | 0.130 |
Vision abnormalities | 24 (10.4%) | 2 (0.9%) | 0.012 | 0.998 |
Walking troubles | 22 (9.5%) | 18 (7.8%) | 0.071 | — |
Severe headache | 27 (11.7%) | 7 (3%) | 0.147 | — |
Dizziness and incoordination | 33 (14.3%) | 11 (4.8%) | 0.239 | — |
CT detectable brain infarct | 25 (10.9%) | 20 (8.7%) | 0.035 | 0.778 |
CT dense artery sign | 3 (1.3%) | 7 (3%) | 0.073 | — |
Cerebral edema | 4 (1.7%) | 11 (4.8%) | 0.004 | 1.000 |
Wake-up stroke | 35 (15.2%) | 26 (11.3%) | 0.068 | — |
SBP | 147.3 ± 25.8 | 147.2 ± 29.5 | 0.973 | — |
DBP | 86.8 ± 60.4 | 84.5 ± 15 | 0.745 | — |
HR | 80.4 ± 15.5 | 81.8 ± 19.3 | 0.563 | — |
Sat O2 | 96.5 ± 2.1 | 94.4 ± 4.5 | <0.001 | 0.026 |
Temperature | 35.9 ± 2.9 | 35.6 ± 4.4 | 0.555 | — |
Digital glycemia | 130.8 ± 50.1 | 148.7 ± 62 | 0.040 | 0.846 |
Time of symptoms | 1359.6 ± 2697 | 1850.8 ± 4091.4 | 0.330 | — |
Glasgow (initial) | 14.7 ± 1.4 | 13.1 ± 3.2 | <0.001 | 0.008 |
NIHSS (initial) | Median = 1, IR = 3 | Median = 12, IR = 14 | <0.001 | <0.001 |
CT: computed tomography; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; Sat O2: oxygen saturation; NIHSS: National Institutes of Health Stroke Scale; IR = interquartile range; P: according to t-test (continuous variables) or Chi-square test (categorical variables); P *: according to binary logistic regression analysis with significant variables.